PBT fell 74.3% on lower Village revaluations as cash conversion slid

The driver sits inside the Village segment, where the segment result halved from NZ$50.3m to NZ$28.2m — a NZ$22.1m swing that effectively explains the whole PBT decline. Care segment revenue rose to NZ$96.5m but its result was flat at NZ$8.5m, with derived margins easing from 9.3% to 8.8%.

NPAT fell less sharply at -69.6% to NZ$11.2m because the period carried a deeper tax credit (effective rate -29.8% versus -10.4% prior). Operating cash flow dropped 40.2% to NZ$31.4m, cash conversion fell to 81.2% from 144.0%, and gross borrowings rose 43.5% to NZ$503.5m, lifting net debt to NZ$497.6m.

Realised gains from new sales and resales were up 12% per the release, and Care revenue grew, yet the Village segment result halved. That points to a sharp step-down in unrealised fair-value gains on investment property between the periods — accounting-driven rather than evidence that the underlying retirement-living engine has broken. For a reader, this matters because PBT and NPAT in isolation overstate the deterioration.

Cash quality weakened materially. OCF/EBITDA at 81.2% is below the historical baseline (3-period mean 166.6%, range 127.6%–190.3%), and OCF fell NZ$21.1m year-on-year despite higher revenue. Pre-lease free cash flow remained negative at -NZ$4.5m even though capex was cut 69% to NZ$35.8m. This matters because the development-led model depends on cash recycling through unit sales, and the headline lift in realised gains has not yet translated into stronger cash generation.

Dividend is not covered by current-period earnings or cash. At 1.9 cents per share (down from 2.1c), the payout ratio is 118.8% of NPAT and -298.5% against pre-lease FCF. Combined with gross borrowings up NZ$152.7m and the facility-size increase referenced in commentary, the distribution is effectively debt-funded this half.

The supplied second-half shape shows HY22 contributed 60.4% of FY22 NPAT and 49.3% of revenue — the prior comparable was first-half-weighted on profit, which amplifies the optics of the current decline. Annualised on current revenue, the run-rate is NZ$244.2m, modestly above FY22's NZ$231.1m.

What the release does not support is any view on the trajectory of investment-property fair-value movements in 2H, which is the single biggest swing factor for reported profit. Without a target or a revaluation outlook, the second-half read rests on whether realised sales momentum continues and whether OCF rebuilds to historical ranges.

The realised-gains commentary (+12%) reinforces that. The weakness sits in two places: cash conversion materially below baseline, and a Village result heavily dependent on revaluation accounting that is volatile by nature.

Leverage of 12.9x net debt/EBITDA is, on the supplied historical baseline, actually below the 15.73x three-period mean — favourable in relative terms but still high in absolute terms, and trending the wrong way versus the prior comparable (9.2x). ROE compressed to 2.3% from 8.1%, consistent with the revaluation-driven profit drop rather than a structural margin issue. Trade receivables of NZ$87.0m and debtor days of 129.6 (vs prior 110.4) sit at the upper edge of the supplied historical range and warrant monitoring as a working-capital signal.

This briefing cannot assess the underlying split between realised retirement-village margin and property revaluation effects without the segment fair-value disclosures from the full interim report.